Department of Medical and Surgical Specialties, Faculty of Medicine, Transylvania University of Brasov, 500019 Brasov, Romania.
Department of Fundamental, Prophylactic and Clinical Sciences, Faculty of Medicine, University Transilvania of Brasov, 500019 Brasov, Romania.
Int J Mol Sci. 2021 Jan 10;22(2):629. doi: 10.3390/ijms22020629.
Cervical cancer represents one of the leading causes of cancer-related death in women all over the world. The infection with human papilloma virus (HPV) is one of the major risk factors for the development of premalignant lesions, which will progress to cervical cancer. Seaweeds are marine organisms with increased contents of bioactive compounds, which are described as potential anti-HPV and anti-cervical cancer agents. Our study aims to bring together all the results of the previous studies, conducted in order to highlight the potency of bioactive molecules from seaweeds, as anti-HPV and anti-cervical agents. This paper is a review of the English literature published between January 2010 and August 2020. We performed a systematic study in the Google Academic and PubMed databases using the key words "HPV infection", "anticancer", "seaweeds", "cervical cancer" and "carcinogenesis process", aiming to evaluate the effects of different bioactive molecules from marine algae on cervical cancer cell lines and on HPV-infected cells. Only original studies were considered for our research. None of the papers was excluded due to language usage or affiliation. Recent discoveries pointed out that sulfated polysaccharides, such as dextran sulfate heparan or cellulose sulfate, blocked the ability of HPV to infect cells, and inhibited the carcinogenesis process. Carrageenans inhibited the virions of HPV from binding the cellular wall. Fucoidan induced the growth inhibition of HeLa cervical cells in vitro. Heterofucans exhibited antiproliferative effects on cancer cell lines. Terpenoids from brown algae are also promising agents with anti-cervical cancer activity. Considering all the results of the previous studies, we observed that great amounts of bioactive molecules from seaweeds could treat both unapparent HPV infection and clinical visible disease. Furthermore, these molecules were very efficient in the treatment of invasive cervical carcinomas. In these conditions, we consider seaweeds extracts as a novel and challenging therapeutic strategy, and we hope that our study paves the way for further clinical trials in the field.
宫颈癌是全世界女性癌症相关死亡的主要原因之一。人乳头瘤病毒(HPV)感染是癌前病变发展的主要危险因素之一,而癌前病变会进展为宫颈癌。海藻是具有较高生物活性化合物含量的海洋生物,被描述为具有抗 HPV 和抗宫颈癌作用的潜在药物。本研究旨在汇集之前所有研究的结果,以突出海藻生物活性分子作为抗 HPV 和抗宫颈癌药物的潜力。这是一篇综述,综合了 2010 年 1 月至 2020 年 8 月期间发表的英文文献。我们在 Google 学术和 PubMed 数据库中使用了“HPV 感染”、“抗癌”、“海藻”、“宫颈癌”和“癌变过程”等关键词进行了系统研究,旨在评估不同海洋藻类生物活性分子对宫颈癌细胞系和 HPV 感染细胞的影响。我们的研究仅考虑了原始研究。由于语言使用或所属机构的原因,没有排除任何一篇论文。最近的发现表明,硫酸多糖(如葡聚糖硫酸肝素或纤维素硫酸)可阻断 HPV 感染细胞的能力,并抑制癌变过程。卡拉胶可抑制 HPV 病毒粒子与细胞壁结合。岩藻聚糖硫酸酯可诱导体外 HeLa 宫颈癌细胞生长抑制。杂合岩藻聚糖对癌细胞系表现出抗增殖作用。褐藻中的萜类化合物也是具有抗宫颈癌活性的有前途的药物。考虑到之前所有研究的结果,我们观察到大量来自海藻的生物活性分子可以治疗无症状 HPV 感染和临床可见疾病。此外,这些分子在治疗浸润性宫颈癌方面非常有效。在这些情况下,我们认为海藻提取物是一种新颖而具有挑战性的治疗策略,我们希望我们的研究为该领域的进一步临床试验铺平道路。